Diabetes therapy
Researchers from Xi'an Technological University have made significant advancements in understanding the dynamic behavior of diabetes mellitus, a complex endocrine disorder. By developing a novel diabetes model with nonlinear impulsive control, the team has shed light on the intricate relationships between insulin, glucose, and glucocorticoid concentrations. This breakthrough
Diabetes therapy
A recent study has shed light on the impact of the menstrual cycle on glycemic control in adolescent females with type 1 diabetes. The research, conducted at Cairo University, found that the hormonal variation during the menstrual cycle significantly affects the need for basal insulin dose adjustments in young women
Diabetes therapy
Research conducted at Chengdu University in Sichuan, People's Republic of China, has found that acupuncture can significantly reduce blood glucose levels in patients with type 2 diabetes. The study, published in the Postgraduate Medical Journal, involved a systematic review and meta-analysis of 20 randomized controlled trials that enrolled
Diabetes therapy
Researchers from Universitas Andalas in Indonesia have conducted a study to examine the relationship between self-care behaviors, physiological indicators, and quality of life in patients with type 2 diabetes mellitus. The study, published in the Belitung Nursing Journal, found that self-maintenance significantly predicted quality of life, while self-monitoring and self-management
Diabetes therapy
A new study examining the effects of type 2 diabetes on corneal densitometry has been conducted by researchers at the Ankara Bilkent City Hospital in Turkey. The study, published in the journal BMC Ophthalmology, aimed to analyze corneal densitometry values in individuals diagnosed with type 2 diabetes mellitus and compare
Diabetes therapy
A new study published in the Obesity journal sheds light on the growing prevalence of obesity among patients with type 1 diabetes, highlighting the need for effective weight management strategies. The research, conducted by a team of experts from the Wake Forest University School of Medicine, suggests that obesity treatment
Diabetes therapy
According to a recent study published in Current Atherosclerosis Reports, glucagon-like peptide-1 receptor (GLP-1R) agonists have emerged as a multifaceted therapeutic option for addressing cardiovascular-kidney-metabolic (CKM) syndrome, microvascular dysfunction, and metabolic-associated steatohepatitis (MASH). These medications, originally developed for glycemic control in diabetes mellitus (DM), are now being explored for their
Diabetes therapy
A new study exploring the self-management of type 2 diabetes in adults living in Wales has identified a need for more person-centred, relational, and contextually sensitive models of care. The study, conducted by Bangor University, found that participants with type 2 diabetes experience self-management as a fluctuating, emotionally charged process
Diabetes therapy
Research at the University of Southern Denmark has shed light on the complexities of type 2 diabetes self-management, particularly when it comes to behavioral lifestyle interventions. A new report highlights the challenges individuals with type 2 diabetes face when participating in personalized e-health behavioral lifestyle interventions. The study, conducted in
Diabetes therapy
New research published in The Journal of Arthroplasty has found that the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) may significantly improve clinical outcomes in patients with obesity or diabetes undergoing total hip and knee arthroplasty. The study, conducted by a team of researchers from Boston University, analyzed data from
Diabetes therapy
A new study published in the journal Sleep and Breathing has shed light on the risk of hyperlactatemia in patients with obstructive sleep apnea (OSA) receiving metformin. The research, conducted by investigators from the Jagiellonian University Medical College, aimed to identify factors affecting lactate concentrations and the consequent risk of
Diabetes therapy
A new study from Universiti Kebangsaan Malaysia aims to evaluate the efficacy of diabetes-specific meal replacements for glycaemic control in overweight and obese patients with type 2 diabetes mellitus (T2DM). The researchers plan to conduct a randomised controlled trial to assess the impact of meal replacement therapy on weight loss,
